The sensitivity of detecting Ta tumor was also superior to the reported methylation assays by DLX1 and ITGA4 (50.0–84.6%) and BCL2, CDKN2A and NID2 (61.1%) [24, 26]. This evidence concerns the gene BCL2 and neoplasm.